Prothrombin time and INR: one measurement, two writings
Prothrombin time (PT) is the raw laboratory result: how many seconds plasma takes to clot via the extrinsic pathway. INR is the standardized form of the same measurement: the laboratory recalculates PT with an adjustment for its reagent's sensitivity so that results from different laboratories can be compared. That is why the two travel as a pair and do not contradict each other.
The main applied role of INR is monitoring warfarin: the dose is titrated to a target INR range set by the clinician. Outside that task, PT and INR are read as an assessment of the extrinsic clotting pathway and the liver's synthetic function: the factors of this pathway are produced exactly there.
APTT and thrombin time: the intrinsic pathway and the final step
APTT covers the intrinsic and common pathways of the cascade: it lengthens with factor deficiencies, on heparin and with inhibitor antibodies in the sample. Thrombin time is the very end of the chain: the conversion of fibrinogen to fibrin. It lengthens with shortage or defects of fibrinogen, with excess breakdown products and under heparin's influence.
The pair 'APTT plus thrombin time' localizes the problem: both lengthened with normal fibrinogen points to inhibitors and interferences; isolated thrombin time lengthening points to the fibrinogen line and its quality.
Antithrombin III: the system's main brake
Antithrombin III is the natural anticoagulant: it quenches the key clotting enzymes and keeps a clot from growing without need. With its inherited shortage the risk of venous thrombosis rises — one of the classic thrombophilias; its acquired reduction occurs in liver disease, nephrotic syndrome and in the acute phase of thrombosis, when antithrombin is consumed.
A practical detail: heparin works precisely through antithrombin — the drug speeds its action hundreds of times. With deep inherited antithrombin deficiency, standard heparin works weakly, which explains rare cases of 'heparin resistance' in hospital.
Lupus anticoagulant: the paradoxical antibody
The lupus anticoagulant is an antibody that lengthens phospholipid-dependent tests (APTT) in the laboratory tube but, in the body, raises the risk of thrombosis and obstetric complications. It is the main laboratory sign of antiphospholipid syndrome. Testing is multi-step: first screening, then confirmation with excess phospholipids and exclusion of other causes of prolongation.
Key reading rules: a single positivity means nothing — the antibody is retested after a set interval, because transient rises occur after infections. Anticoagulant intake distorts the test, so timing and conditions are agreed with the clinician in advance.
When the extended coagulation panel is needed
- Venous thrombosis at a young age or without an obvious cause
- Thromboses in close relatives — a search for inherited thrombophilia
- Recurrent obstetric complications in the history
- Unexplained APTT prolongation in the basic panel
- Surgical preparation with a burdened history
Markers covered in this article
Several markers on your report?
See how MedProtect explains results in the app: the whole report, a check of the recognized values, and a clear breakdown.
Frequently asked questions
How does INR differ from prothrombin time?
Why is antithrombin III drawn?
Lupus anticoagulant is positive — what does it mean?
APTT is long but the doctor talks about thrombosis?
How to prepare for the extended panel?
Sources
- Antithrombin (AT) Activity: Labcorp test directory — Labcorp. Accessed: August 31, 2026.
- Prothrombin time (PT): MedlinePlus Medical Encyclopedia — MedlinePlus, US National Library of Medicine. Accessed: August 31, 2026.
- Lupus Anticoagulant Testing: Lab Tests Online — Testing.com (AACC). Accessed: August 31, 2026.